LTCH
Latch, Inc.
$0.2000
+5.26%
No data for this timeframe.
Vol
Reddit Sentiment50° Neutral
Recent Activity
Jun 3, 2026
Insider
Patel Priyen N surrendered for taxes 3,447 shares
Chief Strategy & Legal Officer @ $0.1400 ($482.58)
Analyst Ratings
3Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 25, 2022 | Keefe, Bruyette & Woods | DOWNGRADE | Market Perform → Underperform |
| Feb 8, 2022 | Colliers Securities | INITIATE | Buy |
| Jan 21, 2022 | DA Davidson | INITIATE | Buy |
| Jan 11, 2022 | Berenberg | INITIATE | Buy |
| Nov 18, 2021 | Imperial Capital | INITIATE | Outperform |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 3, 2026 | Patel Priyen | F | $482.58 |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 1 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Patel Priyen N | Chief Strategy & Legal Officer | TAX W/H | 3,447 | $0.1400 | $482.58 |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jul 2022): 88% buy across 8 analysts — 3 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2022-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2022-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
11 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 10 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jul 25, 2022 | Keefe, Bruyette & Woods | DOWNGRADE | Market Perform | Underperform |
| Feb 8, 2022 | Colliers Securities | INITIATE | — | Buy |
| Jan 21, 2022 | DA Davidson | INITIATE | — | Buy |
| Jan 11, 2022 | Berenberg | INITIATE | — | Buy |
| Nov 18, 2021 | Imperial Capital | INITIATE | — | Outperform |
| Oct 18, 2021 | Goldman Sachs | DOWNGRADE | Buy | Neutral |
| Oct 5, 2021 | B of A Securities | INITIATE | — | Underperform |
| Aug 18, 2021 | Keybanc | INITIATE | — | Sector Weight |
| Jul 29, 2021 | Goldman Sachs | INITIATE | — | Buy |
| Jul 9, 2021 | William Blair | INITIATE | — | Outperform |
| Jul 1, 2021 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Jun 17, 2021 | Baird | INITIATE | — | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jul 1, 2023 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Jun 1, 2023 | 3 | 4 | 1 | 0 | 0 | 88% | |
| May 1, 2023 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Apr 1, 2023 | 3 | 4 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
1 mentions
0 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Sep 20, 2024 | 1 | 56° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.